Search Results 1971-1980 of 19663 for Hemoglobin

1. A Study of Taxane, Trastuzumab, and Pertuzumab With or Without Atezolizumab in Treating Metastatic Breast Cancer Patients - Mayo Clinic

   Hemoglobin must be ≥ 8 g/dL (within 14 days prior to randomization). Total bilirubin must be ≤ 1.5 x upper limit of normal (ULN) for the lab or direct ...

2. A Study of TAK-981 in Combination with Rituximab in Participants with Relapsed/Refractory (r/r) CD20-positive (CD20+) Non-Hodgkin Lymphoma (NHL) - Mayo Clinic

   Hemoglobin ≥ 85 gram per liter (g/L) (red blood cell [RBC] transfusion allowed ≥ 14 days before assessment). Adequate renal and hepatic function, per ...

3. Study Evaluating the Safety and Effectiveness of JCARH125 in Subjects with Relapsed and/or Refractory Multiple Myeloma (EVOLVE) - Mayo Clinic

   Adequate bone marrow function, defined as absolute neutrophil count (ANC) ≥ 1000 cells/mm3 , hemoglobin (Hb) ≥ 8 g/dL, and platelet count ≥ 50,000/mm^3.

4. A Study to Evaluate the Safety and Tolerability of DCC-2618 in Patients with Advanced Malignancies - Mayo Clinic

   Solid Tumor Patients: Bone Marrow Function; Absolute neutrophil count (ANC) ≥ 1500/µL; Hemoglobin ≥ 9 g/dL; Platelet count ≥ 75,000/µL. All Patients ...

5. Publications - Joe Zein, M.D., Ph.D. - Mayo Clinic

   Somatic cell hemoglobin modulates nitrogen oxide metabolism in the human airway epithelium. Sci Rep. 2021 Jul 29; 11 (1):15498 Epub 2021 July 29. View PubMed ...

6. A Study of Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for Relapsed Multiple Myeloma - Mayo Clinic

   Hemoglobin ≥8.0 g/dL; Absolute neutrophil count (ANC) ≥1000/mm3; Platelet count ³50,000/mm3 Note: It is not permissible to transfuse subjects to achieve ...

7. A Study To Evaluate The Efficacy And Safety Of Obinutuzumab In Patients With ISN/RPS 2003 Class III Or IV Lupus Nephritis - Mayo Clinic

   Hemoglobin < 7 g/dL, unless caused by autoimmune hemolytic anemia resulting from SLE. Platelet count < 25,000/µL. Positive serum human chorionic ...

8. A Study of Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma - Mayo Clinic

   Bone Marrow: Absolute neutrophil count (ANC) ≥ 1,500/mm^3; Platelets ≥ 100,000/mm^3; Hemoglobin ≥ 9.0 g/dL;; Renal function: Serum creatinine ≤ 1.5 X ...

9. Phase 2a Open-Label Pilot Study Of VTX2735 In Recurrent Pericarditis - Mayo Clinic

   Hemoglobin < 9 g/dL f. AST or ALT ≥ 2.0 × ULN; Total bilirubin level > 1.5 × ULN unless the participant has been diagnosed with Gilberts' disease and this ...

10. Neurosurgery - Clinical trials

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...